The name on this seller's pages and the name in its address have nothing to do with each other, which matters more than it sounds: a reader who searches for one will not find the other. It names five of the compounds this site tracks and prices none of them.
What Institute for Healthy Aging charges
Institute for Healthy Aging does not publish a price today.
Institute for Healthy Aging also sells 5 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), CJC-1295 (board ranks no provider), Epitalon (board ranks no provider), Ipamorelin (board ranks no provider) and MOTS-C (board ranks no provider).
Institute for Healthy Aging is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The brand and the address do not correspond
The copyright line carries a full institutional name; the address carries an unrelated abbreviation.
A reader who has seen one has no way to guess the other, and a search for either will not surface the second.
That is a discoverability problem the seller has created for itself, and it is worth recording because this comparison is one of the few places both appear together.
It is not a defect in the offer, but it is a fact about finding it.
Five compounds, each named twice
The service page names five tracked compounds, several of them in two spellings each.
Duplicate spellings inflate a naive count, so the figure recorded here is of distinct compounds rather than of matches.
That distinction is the difference between a five-compound menu and a twelve-compound one, and only one of those is true.
The page is a service description rather than a catalogue, and nothing links to a per-compound record.
Nothing here carries a figure
No dollar sign appears anywhere on the service page.
On documentation there is nothing to weigh: no certificate of analysis is claimed and none is linked, on either page read.
Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.
Three things this seller does not publish
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares five of the sixteen compounds this site tracks, and forty-eight sellers here declare more, so it is an above-average menu rather than a wide one.
Who it's for
Readers who want a small, clearly named compound list.
Buyers near the seller's single office.
Shoppers who will be quoted at a consultation.
Anyone comparing sellers whose brand and address diverge.
Who should look elsewhere
Anyone who needs a figure.
Readers who want a company name.
Buyers who need a state footprint.
Shoppers looking for sermorelin, NAD+, GHK-Cu or PT-141, none of which is named.
Strengths
Names five tracked compounds clearly on a single service page
Describes what it offers without claiming an approval it does not have
Keeps its peptide offer separate from its other lines on the page
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Its brand and its address do not correspond, so neither leads a searcher to the other
Publishes no figure for any compound on the pages read
Publishes no corporate entity, so there is no company a reader can look up
Publishes no state list and names no dispensing pharmacy
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Counted distinct compounds rather than pattern matches, because several names appear in two spellings on this page and a match count would have doubled the menu.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare Institute for Healthy Aging against
Live Vital
Live Vital lists one of the deeper peptide menus in this roster — tesamorelin, CJC-1295, ipamorelin, BPC-157, TB-500, GHK-Cu, MOTS-C, glutathione and NAD+ — alongside its GLP-1 line, with coverage across all 50 states.